UCSF Autism Studies

This business has not yet been claimed by the owner or a representative.

Claim this business to view business statistics, receive messages from prospective customers, and respond to reviews.


University of California San Francisco

Age Group:   2 - 5 yrs. old, 6 - 12 yrs. old, 13-18 yrs. old

Category: Special Resources
CBD study: 12 weeks of study medication (cannabidiol (Epidyolex) or placebo) for ages 6-17 to evaluate change in symptoms in Autism Spectrum Disorder
  • Assessment for the diagnosis of autism and to assess the severity of autism
  • 3 clinic visits to UCSF and 7 telephone visits
  • There will be blood draws and ECG
  • Exclusion criteria

ADHD or other diagnoses that dominates the clinical presentation Axial study (Gut Metabolite Supplementation): 8 weeks trial of study medication or placebo for ages 13-17 with GI symptoms to evaluate the effects of this supplement, which coats irritating metabolites in the gut to attempt to reduce irritability in Autism.

  • 6 clinic visits to UCSF and 3 phone visits
  • Exclusion criteria : history of inflammatory bowel disease, history of diabetes, certain medications.
  • There will be blood draws and ECG
ANCHOR (Irritability Associated with ASD; Otsuka) Study: Brexpiprazole is a recently developed medication to reduce irritability associated with Autism: Treatment with study medication (medication or placebo) for 8 weeks for ages 5-17 followed by extension study (on medication) for 26 weeks.


  • Combination of 4 clinic visits at UCSF, 4 virtual visits and one phone visit.
  • There will be blood draws, ECG and testing.
  • Monday
  • Tuesday
  • Wednesday
  • Thursday
  • Friday
  • Saturday
  • Sunday
Reviews (0)

Write a review